StockSelector.com
  Research, Select, & Monitor Saturday, December 15, 2018 8:21:38 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Melinta Therapeutics, Inc.$1.18($.11)(8.53%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Melinta Therapeutics, Inc. has an overall rank of 6562 out of 7471 stocks based on 9 positive rankings and 6 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $11.50 for Melinta Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Melinta Therapeutics is ranked 1.
Oversold Stochastics
Melinta Therapeutics rank is 87
Low Put/Call
Melinta Therapeutics has a low Put/Call ratio of 0.10 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Melinta Therapeutics is ranked 247.
Up EPS Surprise
Melinta Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Price-to-Book
Melinta Therapeutics rank is 443
Low vPut/Call
Melinta Therapeutics has a low Put/Call ratio of 0.31 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Melinta Therapeutics is ranked 569.
Oversold RSI
The 14 Day Relative-Strength Index for Melinta Therapeutics is 27.6. An RSI below 30 indicates the stock is oversold. Among companies with a low RSI, Melinta Therapeutics is ranked 569.
Price-to-Sales
Melinta Therapeutics rank is 1740
Debt-to-Equity
Melinta Therapeutics rank is 2446
Negative Rankings
10 Day Loss
Melinta Therapeutics rank is 37
90 Day Loss
Melinta Therapeutics rank is 97
Negative Net Margin
Melinta Therapeutics rank is 384
Negative ROE
Melinta Therapeutics rank is 426
Negative Cash Growth
Melinta Therapeutics rank is 574
Negative ROA
Melinta Therapeutics rank is 701







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.